Ngā hua rapu - Nilesh Gupta

  • E whakaatu ana i te 1 - 18 hua o te 18
Whakamahine hua
  1. 1
    Nano-Engineered Erythrocyte Ghosts as Inhalational Carriers for Delivery of Fasudil: Preparation and Characterization

    Nano-Engineered Erythrocyte Ghosts as Inhalational Carriers for Delivery of Fasudil: Preparation and Characterization mā Nilesh Gupta, Brijeshkumar Patel, Fakhrul Ahsan

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Fasudil and SOD packaged in peptide-studded-liposomes: Properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs

    Fasudil and SOD packaged in peptide-studded-liposomes: Properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs mā Nilesh Gupta, Fahad Alsaikhan, Brijeshkumar Patel, Jahidur Rashid, Fakhrul Ahsan

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Anastomosing Hemangioma of the Genitourinary System

    Anastomosing Hemangioma of the Genitourinary System mā Oleksandr N. Kryvenko, Nilesh Gupta, Frederick A. Meier, Min Won Lee, Jonathan I. Epstein

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Gleason Score 7 Adenocarcinoma of the Prostate With Lymph Node Metastases: Analysis of 184 Radical Prostatectomy Specimens

    Gleason Score 7 Adenocarcinoma of the Prostate With Lymph Node Metastases: Analysis of 184 Radical Prostatectomy Specimens mā Oleksandr N. Kryvenko, Nilesh Gupta, Nilam Virani, Daniel Schultz, Juan Farak Gómez, Ali Amin, Zhaoli Lane, Jonathan I. Epstein

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer

    Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer mā Vipul Bhatia, Anjali Yadav, Ritika Tiwari, Shivansh Nigam, Sakshi Goel, Shannon Carskadon, Nilesh Gupta, Apul Goel, Nallasivam Palanisamy, Bushra Ateeq

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity

    Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity mā Sean R. Williamson, Liang Cheng, John N. Eble, Lawrence D. True, Nilesh Gupta, Ming‐Sheng Wang, Shaobo Zhang, David J. Grignon

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension

    Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension mā Vivek Gupta, Nilesh Gupta, Imam H. Shaik, Reza Mehvar, Ivan F. McMurtry, Masahiko Oka, Eva Nozik‐Grayck, Masanobu Komatsu, Fakhrul Ahsan

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Peptide-Coated Liposomal Fasudil Enhances Site Specific Vasodilation in Pulmonary Arterial Hypertension

    Peptide-Coated Liposomal Fasudil Enhances Site Specific Vasodilation in Pulmonary Arterial Hypertension mā Kamrun Nahar, Shahriar Absar, Nilesh Gupta, Venkata Ramana Kotamraju, Ivan F. McMurtry, Masahiko Oka, Masanobu Komatsu, Eva Nozik‐Grayck, Fakhrul Ahsan

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma

    Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma mā Sean R. Williamson, John N. Eble, Mohammed A. Amin, Nilesh Gupta, Steven C. Smith, Lynette M. Sholl, Rodolfo Montironi, Michelle S. Hirsch, Jason L. Hornick

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity

    Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity mā Khaleel I. Al‐Obaidy, John N. Eble, Mehdi Nassiri, Liang Cheng, Mohammad K. Eldomery, Sean R. Williamson, Wael Sakr, Nilesh Gupta, Oudai Hassan, Muhammad T. Idrees, David J. Grignon

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer

    Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer mā Ritika Tiwari, Nishat Manzar, Vipul Bhatia, Anjali Yadav, Mushtaq Ahmad Nengroo, Dipak Datta, Shannon Carskadon, Nilesh Gupta, Michael Sigouros, Francesca Khani, Matti Poutanen, Amina Zoubeidi, Himisha Beltran, Nallasivam Palanisamy, Bushra Ateeq

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    ERG gene rearrangements are common in prostatic small cell carcinomas

    ERG gene rearrangements are common in prostatic small cell carcinomas mā Tamara L. Lotan, Nilesh Gupta, Wenle Wang, Antoun Toubaji, Michael C. Haffner, Alcides Chaux, Jessica Hicks, Alan K. Meeker, Charles J. Bieberich, Angelo M. De Marzo, Jonathan I. Epstein, George J. Netto

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM

    Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM mā Dejuan Kong, Elisabeth I. Heath, Wei Chen, Michael L. Cher, Isaac J. Powell, Lance K. Heilbrun, Yiwei Li, Shadan Ali, Seema Sethi, Oudai Hassan, Clara Hwang, Nilesh Gupta, Dhananjay Chitale, Wael Sakr, Mani Menon, Fazlul H. Sarkar

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma

    Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma mā Hsueh-Li Tan, Anil K. Sood, Hameed A. Rahimi, Wenle Wang, Nilesh Gupta, Jessica Hicks, Stacy Mosier, Christopher D. Gocke, Jonathan I. Epstein, George J. Netto, Wennuan Liu, William B. Isaacs, Angelo M. De Marzo, Tamara L. Lotan

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas

    Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas mā Harrison Tsai, Carlos L. Morais, Mohammed Alshalalfa, Hsueh‐Li Tan, Zaid Haddad, Jessica Hicks, Nilesh Gupta, Jonathan I. Epstein, George J. Netto, William B. Isaacs, Jun Luo, Rohit Mehra, Robert L. Vessella, R. Jeffrey Karnes, Edward M. Schaeffer, Elai Davicioni, Angelo M. De Marzo, Tamara L. Lotan

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer

    Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Can... mā Svend O. Freytag, Hans Stricker, Mei Lü, Mohamed A. Elshaikh, Ibrahim Aref, Deepak Pradhan, Kenneth Levin, Jae Ho Kim, James O. Peabody, Farzan Siddiqui, Kenneth Barton, Jan Pegg, Yingshu Zhang, Jingfang Cheng, Nancy Oja-Tebbe, Renee Bourgeois, Nilesh Gupta, Zhaoli Lane, Ron Rodriguez, Theodore L. DeWeese, Benjamin Movsas

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists

    Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists mā Sean R. Williamson, Ramya Gadde, Kiril Trpkov, Michelle S. Hirsch, John R. Srigley, Victor E. Reuter, Liang Cheng, Lakshmi P. Kunju, Ravi Barod, Craig Rogers, Brett Delahunt, Ondřej Hes, John N. Eble, Ming Zhou, Jesse K. McKenney, Guido Martignoni, Stewart Fleming, David J. Grignon, Holger Moch, Nilesh Gupta

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity

    Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity mā Khaleel I. Al‐Obaidy, Rola Saleeb, Kiril Trpkov, Sean R. Williamson, Ankur R. Sangoi, Mehdi Nassiri, Ondřej Hes, Rodolfo Montironi, Alessia Cimadamore, Andrés Acosta, Zainab Alruwaii, Ahmad Alkashash, Oudai Hassan, Nilesh Gupta, Adeboye O. Osunkoya, Joyashree D. Sen, Lee Ann Baldrige, Wael Sakr, Muhammad T. Idrees, John N. Eble, David J. Grignon, Liang Cheng

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: